Synapse

← Global Cardiology

Papers in Global Cardiology

Page 2 · newest first

  1. Unveiling the genetic aetiology of non-genetic dilated cardiomyopathyGlobal Cardiology · 2024
  2. Biological plausibility and implications of obesity associated valvular heart diseasesGlobal Cardiology · 2024
  3. Modulation of cardiac metabolism in heart failureGlobal Cardiology · 2024
  4. Depression, health-related quality of life and life satisfaction in patients with heart failureGlobal Cardiology · 2024
  5. Clinical profiles and short-term outcomes of women with peripartum and dilated cardiomyopathiesGlobal Cardiology · 2024
  6. New left ventricular thrombus and embolic events in left ventricular dysfunction postmyocardial infarctionGlobal Cardiology · 2024
  7. To clip or not to clip moderate-to-severe functional mitral regurgitation in patients with heart failure?Global Cardiology · 2024
  8. Using multiple primary endpoints in clinical trials with a focus on heart failureGlobal Cardiology · 2024
  9. Baseline echocardiographic characteristics of patients enrolled in the randomized investigation of MitraClip device in heart failure (RESHAPE HF-2) trial: comparison with COAPT and Mitra-FRGlobal Cardiology · 2024
  10. Exercise capacity, iron deficiency and depressive symptoms in patients with asymptomatic chronic systolic heart failureGlobal Cardiology · 2024
  11. Epidemiology of peripartum cardiomyopathy in AfricaGlobal Cardiology · 2024
  12. Prevalence of left ventricular dysfunction and relationship with serum selenium in apparently healthy pregnant women: results from the PEACE registryGlobal Cardiology · 2024
  13. Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patientsGlobal Cardiology · 2024
  14. Bibliometric analysis of cardiovascular disease research activity in the Arab worldGlobal Cardiology · 2024
  15. Global Cardiology issue highlightsGlobal Cardiology · 2024
  16. Preliminary study on the immunohistochemical expression of galectin-3 in hypertrophic heartsGlobal Cardiology · 2024
  17. The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysisGlobal Cardiology · 2024
  18. The impact of diurnal fasting during Ramadan on patients with established cardiac disease: a systematic reviewGlobal Cardiology · 2024
  19. Elevated left ventricular end diastolic pressure, chronic pulmonary oedema and valve diseaseGlobal Cardiology · 2024
  20. Clinical trial design, endpoints and regulatory considerations in heart failureGlobal Cardiology · 2024
  21. Acute interventional management of spontaneous coronary artery dissection: case series and literature reviewGlobal Cardiology · 2024
  22. Quality of life in Maltese adults with congenital heart disease: a second lookGlobal Cardiology · 2024
  23. COVID-19 myocarditisGlobal Cardiology · 2024
  24. The scientific targets: the myocardium, the vasculature and the body’s response to heart failureGlobal Cardiology · 2024
  25. Anomalous origin of right coronary artery from the pulmonary artery: an incidental finding on cardiac computed tomography in a patient presenting with dyspneaGlobal Cardiology · 2024
  26. Preferential vasodilator effects of levosimendan in resistance pulmonary arteries in a rodent pulmonary embolism modelGlobal Cardiology · 2024
  27. Neck-to-height ratio in Bosnian university students according to the 2017 American College of Cardiology/American Heart Association guidelines on hypertension classificationGlobal Cardiology · 2024
  28. The impact of maternal congenital heart disease on pregnancy outcomes in Malta: a retrospective studyGlobal Cardiology · 2023
  29. The impact of maternal congenital heart disease on pregnancy outcomes in Malta: a retrospective studyGlobal Cardiology · 2023
  30. Detection of early heart failure with preserved ejection fraction in metabolic syndrome patients detected as part of a national screening program in middle aged subjectsGlobal Cardiology · 2023
  31. Detection of early heart failure with preserved ejection fraction in metabolic syndrome patients detected as part of a national screening program in middle aged subjectsGlobal Cardiology · 2023
  32. The impact of maternal congenital heart disease on pregnancy outcomes in Malta: a retrospective studyGlobal Cardiology · 2023
  33. Detection of early heart failure with preserved ejection fraction in metabolic syndrome patients detected as part of a national screening program in middle aged subjectsGlobal Cardiology · 2023
  34. Iron deficiency in heart failure with preserved ejection fraction: rationale and design of the FAIR-HFpEF trialGlobal Cardiology · 2023
  35. Iron deficiency in heart failure with preserved ejection fraction: rationale and design of the FAIR-HFpEF trialGlobal Cardiology · 2023
  36. Iron deficiency in heart failure with preserved ejection fraction: rationale and design of the FAIR-HFpEF trialGlobal Cardiology · 2023
  37. Defining iron replete status in patients with heart failure treated with intravenous ironGlobal Cardiology · 2023
  38. Defining iron replete status in patients with heart failure treated with intravenous ironGlobal Cardiology · 2023
  39. Defining iron replete status in patients with heart failure treated with intravenous ironGlobal Cardiology · 2023
  40. Adherence to lifestyle therapy in patients with chronic heart failure and comorbidityGlobal Cardiology · 2023
  41. Adherence to lifestyle therapy in patients with chronic heart failure and comorbidityGlobal Cardiology · 2023
  42. Adherence to lifestyle therapy in patients with chronic heart failure and comorbidityGlobal Cardiology · 2023
  43. Evolving targets for heart failure: the journey so farGlobal Cardiology · 2023
  44. Evolving targets for heart failure: the journey so farGlobal Cardiology · 2023
  45. Evolving targets for heart failure: the journey so farGlobal Cardiology · 2023
  46. Rationale and design for the peripartum cardiomyopathy in Nigeria (PEACE) registryGlobal Cardiology · 2023
  47. Rationale and design for the peripartum cardiomyopathy in Nigeria (PEACE) registryGlobal Cardiology · 2023
  48. Rationale and design for the peripartum cardiomyopathy in Nigeria (PEACE) registryGlobal Cardiology · 2023
  49. Intervention options: depression and cardiovascular disease during COVID-19Global Cardiology · 2023
  50. Intervention options: depression and cardiovascular disease during COVID-19Global Cardiology · 2023